MedTrace Logo

FSHD Molecular Characterization

NCT06096441 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2025-09-18

No results posted yet for this study

Summary

To characterize the clinical and molecular phenotype of FSHD.

Conditions

  • Facio-Scapulo-Humeral Dystrophy

Sponsors & Collaborators

  • Nationwide Children's Hospital

    lead OTHER

Principal Investigators

  • Kevin Flanigan, MD · Nationwide Children's Hospital

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-05
Primary Completion
2025-09-09
Completion
2025-09-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06096441 on ClinicalTrials.gov